ReviewFrontiers in immunology2024

Protease activated receptor 2 as a novel druggable target for the treatment of metabolic dysfunction-associated fatty liver disease and cancer.

Gianmarco Villano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.